(Q27659612)

English

Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode (English)
0 references
0 references
Matthew Pelc
0 references
Satwik Kamtekar
0 references
Jacqueline Day
0 references
Gennadiy I Poda
0 references
Molly K Hall
0 references
Marshall L Michener
0 references
Beverly A Reitz
0 references
Karl J Mathis
0 references
Betsy S Pierce
0 references
Mihir D Parikh
0 references
Deborah A Mischke
0 references
Scott A Long
0 references
John J Parlow
0 references
David R Anderson
0 references
Atli Thorarensen
0 references
1 March 2010
0 references
20
0 references
5
0 references
1543-7
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit